Manganism (Manganese Toxicity): Occupational and Water Exposure
Manganese is an essential nutrient your body needs in tiny amounts, and getting too much from ordinary food is essentially impossible. But manganese can be toxic when it reaches the body by an unusual route — chiefly breathing it in as welding or smelting fumes, drinking it from contaminated well water, or receiving it intravenously through nutrition fed straight into a vein. When that happens, manganese bypasses the gut's careful gatekeeping, climbs in the blood, and deposits in a deep region of the brain, producing a movement disorder historically called manganism. This page is about those three real-world exposures — how the toxicity feels, why the route of exposure matters so much, and when to seek help. The hallmark symptoms themselves, the parkinsonism and tremor and the mood and cognitive changes, are covered in depth on their own pages; here the focus is the source.
Table of Contents
- What Manganese Toxicity Feels Like
- The Mechanism: Why the Route of Exposure Matters
- An Honest Caveat: Excess Manganese Is an Uncommon Cause
- Clues That Point to Manganese Specifically
- The Three Real Exposures: Fumes, Well Water, and TPN
- Getting Checked
- How Manganese Overload Is Managed
- When to Seek Care / Red Flags
- Key Research Papers
- Connections
- Featured Videos
What Manganese Toxicity Feels Like
The first thing to understand is that manganese toxicity does not come from eating manganese-rich food. Whole grains, nuts, leafy greens, and tea are loaded with manganese, yet they do not cause poisoning, because a healthy gut absorbs only a small fraction of dietary manganese and the liver promptly dumps the excess into bile. Toxicity is a problem of route, not of a healthy diet — it shows up when manganese reaches the blood by inhalation, by drinking water in which it is dissolved at high concentration, or by direct infusion into a vein. For that reason, manganism is largely a condition of certain workers, of households on certain private wells, and of patients on long-term intravenous feeding.
When manganese does build up, it settles preferentially in a deep brain structure called the globus pallidus (part of the basal ganglia, the brain's movement-control hub), and the resulting illness tends to unfold in two overlapping phases:
- An early, easily-missed phase. Before any obvious movement problem, people often report vague, “not myself” symptoms: irritability, low mood, anxiety, trouble concentrating, slowed thinking, and disturbed sleep. Because these are so common and so unspecific, they are rarely attributed to a metal. These early mental and emotional changes are covered on the mood and cognitive changes page.
- A later movement phase — manganism. With heavier or longer exposure, a parkinsonian movement disorder emerges: slowness of movement (bradykinesia), stiff or rigid muscles, a stooped posture, a distinctive high-stepping “cock walk” gait, soft or slurred speech, and a fine tremor. This cluster — and how it differs from ordinary Parkinson's disease — is detailed on the tremor and parkinsonism page.
The practical point for this page is that the symptoms are driven by the exposure. A welder with months of fume exposure, a child drinking high-manganese well water, and a patient months into intravenous nutrition can all arrive at the same brain region by very different paths. Recognizing the path is often what makes the diagnosis, because the symptoms alone look like several far more common conditions.
The Mechanism: Why the Route of Exposure Matters
To see why food is safe but fumes, well water, and intravenous feeding are not, it helps to follow manganese through the body and notice where the body's defenses sit.
The gut is a tollbooth; the liver is the bouncer. When you eat manganese, the intestine absorbs only a modest percentage of it, and that fraction shrinks further when your body already has enough — absorption is actively dialed down when stores are full. Whatever does get in travels first to the liver, which extracts manganese and excretes it into bile, carrying it back out through the stool. Between the gut tollbooth and the liver bouncer, dietary manganese is kept on a very short leash, which is why a manganese-rich diet does not poison anyone with a healthy gut and liver.
Inhalation skips the tollbooth entirely. Manganese breathed in as fine fume or dust does not pass through the gut at all. Fine particles deposit deep in the lungs and are absorbed straight into the bloodstream, sidestepping the intestine's careful regulation. Worse, some inhaled manganese can travel directly from the nose along the olfactory nerve into the brain, a back-door route that bypasses even the blood-brain barrier. This is why welders and smelter workers — not people who eat manganese-rich food — are the classic occupational victims.
Drinking water partly bypasses the brakes. Manganese dissolved in water is swallowed like food, but two things make high-manganese water risky in a way that food is not. First, the dose can be relentless: a contaminated well delivers manganese with every glass, every day, for years. Second, in infants and young children the gut absorbs a larger fraction and the developing brain is more vulnerable, so the same water concentration that an adult handles can affect a child.
Intravenous feeding removes the gatekeeper completely. In total parenteral nutrition (TPN), nutrients — including manganese — are infused directly into a vein, skipping the gut entirely. There is no intestinal tollbooth to limit absorption; essentially 100% of the infused manganese enters the blood. If, on top of that, the patient has liver trouble (cholestasis, where bile flow is blocked), the liver bouncer cannot clear the excess either, so manganese has no easy way out and accumulates rapidly.
An analogy. Think of dietary manganese as a guest arriving at a building with a front desk and a vigilant doorman. Most visitors are turned away at the desk (the gut), and any who slip past are escorted out by the doorman (the liver via bile). Inhaled manganese is a guest climbing through a side window straight onto the top floor — no front desk, sometimes not even a lobby. Intravenous manganese is dropped onto that floor by helicopter, and if the doorman is also out sick (liver disease), there is no one left to remove anyone. Same building, same destination — the deep brain — but the unguarded routes are the ones that flood it.
Once in the brain, manganese concentrates in the globus pallidus, where it disrupts the cells' energy factories (mitochondria) and generates oxidative stress, damaging the neurons that fine-tune movement. Because the target region overlaps with — but is not identical to — the area damaged in Parkinson's disease, the resulting movement disorder resembles Parkinson's yet has its own signature, explored on the tremor and parkinsonism page.
An Honest Caveat: Excess Manganese Is an Uncommon Cause
It would be misleading to read this page and conclude that tremor, slowness, low mood, or brain fog probably mean manganese poisoning. They almost never do. Manganism is a genuinely uncommon diagnosis, and every symptom it produces is produced far more often by something else. Honesty here protects you from chasing a rare metal while a common, treatable cause goes unaddressed.
The early mood and thinking changes — irritability, anxiety, depression, poor concentration, fatigue — are among the most non-specific complaints in all of medicine. Ordinary depression, anxiety disorders, poor sleep, thyroid disease, and medication side effects dwarf manganese as explanations. Likewise, the movement symptoms have a long list of common causes:
- Idiopathic Parkinson's disease is vastly more common than manganism and produces overlapping slowness, stiffness, and tremor. Most parkinsonism is not from manganese. See Parkinson's disease.
- Medication-induced parkinsonism — certain anti-nausea drugs and older antipsychotics block dopamine and can mimic both manganism and Parkinson's; stopping the drug often reverses it.
- Essential tremor and other common tremor disorders.
- Advanced liver disease itself can raise blood manganese and cause a movement disorder even without any external exposure, because the failing liver cannot clear normal dietary manganese — a reminder that the liver, not the diet, is usually the deciding factor.
So manganese excess earns serious consideration only when the exposure history fits — a relevant job, a tested well, or intravenous nutrition. Without one of those, it sits near the bottom of the list. The next section describes the clues that move it up.
Clues That Point to Manganese Specifically
A handful of features should raise manganese toward the top of the list rather than the bottom. The strongest by far is a fitting exposure; the rest are supporting hints.
- An occupational or environmental exposure that fits. This is the single most important clue. Years of welding, especially in confined or poorly ventilated spaces, or work in steel, ferroalloy, smelting, battery, or manganese-mining settings. A private well, particularly one with rusty staining, a metallic taste, or a previous high-manganese test result. Or long-term intravenous nutrition, especially with any liver/bile problem. No fitting exposure, no manganism.
- Symptoms that improve when the exposure stops. If vague mood or movement symptoms ease during a long break from the job or after a move away from the well, that pattern is suggestive (though, importantly, advanced manganism can persist even after exposure ends).
- A parkinsonism with an “off-Parkinson's” flavor. Manganism tends to spare the classic Parkinson's resting tremor, favor early balance and gait trouble (including the toe-walking “cock gait”), and — the key differentiator — respond poorly to levodopa, the mainstay Parkinson's drug. A parkinsonism that does not respond to levodopa earns a second look at the exposure history. The distinctions are detailed on the tremor and parkinsonism page.
- A telltale MRI. Because manganese is paramagnetic, its accumulation in the globus pallidus produces a characteristic bright signal on a specific (T1-weighted) brain MRI — a fairly distinctive fingerprint when the clinical picture and exposure already fit.
Two or more of these together — a fitting exposure plus a levodopa-resistant parkinsonism, say, or a relevant job plus the classic MRI finding — is when manganese stops being a long shot and becomes a leading possibility worth testing for directly.
The Three Real Exposures: Fumes, Well Water, and TPN
Practically all human manganese toxicity traces to one of three sources. Each has its own at-risk group and its own prevention.
1. Welding and other occupational fumes
This is the classic and best-documented cause. Welding rods and the steel they join contain manganese, and the electric arc vaporizes it into an ultrafine fume that hangs in the air and is breathed deep into the lungs. The risk is highest with poor ventilation — welding inside tanks, ship hulls, boilers, or other confined spaces — and rises with cumulative hours over the years. Studies of welders have linked higher fume exposure to measurable neurological and neuropsychological changes, and a long-term study found that parkinsonian signs in welders worsened in step with how much fume they had inhaled over time. The same hazard exists in steel and ferroalloy production, smelting, dry-cell battery manufacturing, and manganese mining and ore processing.
Prevention is the real medicine here: local exhaust ventilation that captures fume at the source, fitted respirators, working in open air where possible, and workplace air and biological monitoring. There is no antidote that undoes accumulated brain damage, so keeping the fume out of the lungs in the first place is what matters.
2. High-manganese well water
Manganese is a natural component of soil and rock, so it dissolves into groundwater and can reach high levels in some private wells — which, unlike public water systems, are not routinely tested or treated. The clearest human concern is in children: a well-known study of school-age children found that those drinking water with higher manganese had measurably lower IQ scores, with the effect tracking the water concentration. Infants are especially vulnerable because they absorb a larger fraction of ingested manganese and their brains are still developing; manganese is one reason private-well water is not recommended for mixing infant formula without testing.
Prevention: test private well water for manganese (the U.S. EPA suggests a health-based guidance level of about 0.3 mg/L, and a lower 1-day limit of 1 mg/L for infants); if it is high, treatment options include ion-exchange (water softening), oxidation-filtration, or reverse osmosis, or switching to a tested alternative source for drinking and cooking. Boiling does not remove manganese — it concentrates it.
3. Total parenteral nutrition (TPN)
People who cannot eat — because of severe gut disease, surgery, or short-bowel syndrome — may be fed intravenously, and these IV nutrition formulas have traditionally included trace manganese. Because the infusion bypasses the gut and goes straight into the blood, and because many of these patients also have impaired bile flow (cholestasis) that blocks the liver's only major route for removing manganese, blood and brain manganese can climb over weeks to months. Both children and adults on long-term TPN have developed high manganese levels, the telltale bright MRI, and in some cases overt parkinsonism. This is the reason modern practice is to use conservative manganese dosing in IV nutrition, to monitor blood manganese and watch liver function, and to reduce or withhold manganese when cholestasis appears.
Across all three, the unifying theme is the one from the mechanism section: manganese becomes dangerous precisely when it reaches the blood by a route that skips the gut and the liver's bile pathway.
Getting Checked
There is no single perfect test for manganese toxicity, so the diagnosis rests on putting the exposure history, the clinical picture, and a few investigations together. The history is the foundation: a clinician will ask in detail about your work (welding, smelting, battery or mining work, and for how long), your drinking water (private well? ever tested?), and any intravenous nutrition.
Testing then typically includes:
- Blood manganese. Most of the body's manganese is inside cells and the brain rather than circulating, so a blood level is an imperfect snapshot — it reflects recent exposure better than total body or brain burden, and can be normal despite a real problem. It is most useful for confirming an ongoing exposure (for example, monitoring a TPN patient or a worker) rather than for ruling toxicity in or out by itself.
- Brain MRI. Because manganese is paramagnetic, its build-up in the globus pallidus shows up as a characteristic bright signal on a T1-weighted scan. When the exposure and symptoms already fit, this imaging finding is one of the more telling pieces of evidence; it tends to fade over months once the exposure stops.
- Liver function tests. A liver panel matters because liver disease and blocked bile flow both impair the body's main route for clearing manganese — relevant in TPN patients and in anyone with chronic liver disease. A broader Comprehensive Metabolic Panel gives a useful overview of liver and kidney function.
- Water testing. When a well is suspected, sending a water sample to a certified lab for manganese is a direct, inexpensive, and decisive step.
Because manganism mimics more common conditions, part of the workup is also excluding the alternatives from the honesty section — reviewing medications that can cause parkinsonism, considering ordinary Parkinson's disease, and assessing thyroid, mood, and sleep when the complaints are mainly mental. Diagnosis is usually best coordinated by a neurologist, often with occupational-medicine or toxicology input.
How Manganese Overload Is Managed
The honest headline is that treatment for established manganism is limited, which is exactly why prevention carries so much weight. Management rests on three ideas: stop the exposure, support the body's own clearance, and treat symptoms — with realistic expectations.
- Remove the source — the single most important step. Get the person away from the fume, the contaminated water, or the manganese-containing infusion. In milder, earlier cases, removing the exposure can allow partial improvement and the bright MRI signal to fade over months, as the body slowly excretes the stored manganese. In advanced cases, however, symptoms can persist or even progress for a time after exposure ends, because neurons have already been injured.
- For TPN specifically, adjust the formula. Reducing or withholding manganese from the IV nutrition (and managing any cholestasis) is the cornerstone fix and can lower blood levels over time. Studies of patients who stopped manganese supplementation have shown blood levels and MRI signal declining over the following months and years.
- Chelation has only a limited role. Chelating agents (such as EDTA) that bind metals for excretion have been tried, with inconsistent results — they can lower blood manganese but do not reliably reverse neurological damage. Chelation is not a routine cure and is used selectively under specialist guidance.
- Symptom-directed care. Because manganese-induced parkinsonism typically responds poorly to levodopa (unlike true Parkinson's disease), drug treatment of the movement disorder is often disappointing. Physical, occupational, and speech therapy to maintain mobility, balance, and communication, and treatment of mood and sleep symptoms, are valuable and frequently the most useful interventions. Specific symptom management is discussed on the tremor and parkinsonism and mood and cognitive changes pages.
The throughline is sobering but clarifying: because there is no reliable way to undo the brain injury, the most powerful tools are upstream — workplace ventilation and respirators, well-water testing and filtration, and cautious, monitored manganese dosing in intravenous nutrition.
When to Seek Care / Red Flags
Manganese toxicity develops slowly, so the priority is recognizing it early — while removing the exposure can still help — rather than waiting for an emergency. Seek medical evaluation if you have a fitting exposure plus any of the following:
- New, persistent movement changes with a relevant exposure — slowness, stiffness, a shuffling or high-stepping gait, frequent stumbling or falls, soft or slurred speech, or a tremor — especially in a welder, smelter or battery worker, or someone on long-term intravenous nutrition.
- New or worsening mood, memory, or concentration problems in someone with a heavy occupational fume exposure or high-manganese well water, particularly if the symptoms ease during time away from the source.
- A child with high-manganese well water showing learning difficulties, attention problems, or developmental concerns — have the water tested and discuss it with the pediatrician.
- A patient on TPN who develops any new tremor, slowness, stiffness, or behavioral change — this warrants prompt review of the manganese in the formula, blood manganese, and liver function.
Sudden, severe symptoms — trouble breathing, chest pain, collapse, or a rapid change in consciousness — are not the pattern of manganism and point to a different, possibly acute problem; those warrant emergency care on their own. For chronic manganese concerns, the right move is a non-urgent but prompt appointment, ideally with a neurologist or occupational-medicine clinician, and — crucially — removing yourself from the suspected source while you are being evaluated. Catching it early, before the movement disorder is entrenched, is the whole point.
Key Research Papers
- Guilarte TR (2010). Manganese and Parkinson's Disease: A Critical Review and New Findings. Environmental Health Perspectives;118(8):1071-1080. — DOI: 10.1289/ehp.0901748
- Kwakye GF, Paoliello MMB, Mukhopadhyay S, et al. (2015). Manganese-Induced Parkinsonism and Parkinson's Disease: Shared and Distinguishable Features. International Journal of Environmental Research and Public Health;12(7):7519-7540. — DOI: 10.3390/ijerph120707519
- Bowler RM, Roels HA, Nakagawa S, et al. (2006). Dose-effect relationships between manganese exposure and neurological, neuropsychological and pulmonary function in confined space bridge welders. Occupational and Environmental Medicine;64(3):167-177. — DOI: 10.1136/oem.2006.028761
- Bowler RM, Koller W, Schulz PE, et al. (2006). Manganese exposure: Neuropsychological and neurological symptoms and effects in welders. NeuroToxicology;27(3):315-326. — DOI: 10.1016/j.neuro.2005.10.007
- Racette BA, Searles Nielsen S, Criswell SR, et al. (2017). Dose-dependent progression of parkinsonism in manganese-exposed welders. Neurology;88(4):344-351. — DOI: 10.1212/WNL.0000000000003533
- Sriram K, Lin GX, Jefferson AM, et al. (2010). Dopaminergic neurotoxicity following pulmonary exposure to manganese-containing welding fumes. Archives of Toxicology;84(7):521-540. — DOI: 10.1007/s00204-010-0525-9
- Roels HA, Bowler RM, Kim Y, et al. (2012). Manganese exposure and cognitive deficits: A growing concern for manganese neurotoxicity. NeuroToxicology;33(4):872-880. — DOI: 10.1016/j.neuro.2012.03.009
- Bouchard MF, Sauvé S, Barbeau B, et al. (2011). Intellectual Impairment in School-Age Children Exposed to Manganese from Drinking Water. Environmental Health Perspectives;119(1):138-143. — DOI: 10.1289/ehp.1002321
- Santos D, Batoreu C, Mateus L, et al. (2014). Manganese in human parenteral nutrition: Considerations for toxicity and biomonitoring. NeuroToxicology;43:36-45. — DOI: 10.1016/j.neuro.2013.10.003
- Tuschl K, Clayton PT, Gospe SM, et al. (2012). Syndrome of Hepatic Cirrhosis, Dystonia, Polycythemia, and Hypermanganesemia Caused by Mutations in SLC30A10, a Manganese Transporter in Man. The American Journal of Human Genetics;90(3):457-466. — DOI: 10.1016/j.ajhg.2012.01.018
- Khindri N, Maj M (2025). Manganese-Induced Parkinsonism: A Review of Etiologies and Treatments. Degenerative Neurological and Neuromuscular Disease;15:65-79. — DOI: 10.2147/DNND.S482018
PubMed Topic Searches
- PubMed — Manganism and occupational welding-fume exposure
- PubMed — Manganese in drinking water and child neurodevelopment
- PubMed — Manganese in parenteral nutrition and hypermanganesemia
- PubMed — Manganese deposition on brain MRI (globus pallidus)
- PubMed — Treatment and chelation in manganese neurotoxicity
Connections
- Manganese Toxicity Hub
- Manganism: Tremor & Parkinsonism
- Manganese: Mood & Cognitive Changes
- Manganese Deficiency Hub
- Manganese Overview
- Manganese Benefits
- Iron
- Parkinson's Disease
- Cirrhosis
- Liver Disease
- Heavy Metals
- Liver Function Tests
- Comprehensive Metabolic Panel